ERBB2 and breast carcinoma: A similar concordance level was observed for advanced breast cancer patients, where an overall concordance of up to 95% (negative and positive) was observed for the detection of mutations from the four major driver genes of breast cancer—PIK3CA, ESR1, AKT1, and HER2 [54].